Leilei Yang

546 total citations · 1 hit paper
13 papers, 410 citations indexed

About

Leilei Yang is a scholar working on Immunology, Occupational Therapy and Pathology and Forensic Medicine. According to data from OpenAlex, Leilei Yang has authored 13 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Occupational Therapy and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Leilei Yang's work include interferon and immune responses (3 papers), Diabetic Foot Ulcer Assessment and Management (3 papers) and Cancer Mechanisms and Therapy (3 papers). Leilei Yang is often cited by papers focused on interferon and immune responses (3 papers), Diabetic Foot Ulcer Assessment and Management (3 papers) and Cancer Mechanisms and Therapy (3 papers). Leilei Yang collaborates with scholars based in China, Philippines and Ireland. Leilei Yang's co-authors include Jianfeng Guo, Zhuo Yu, Yun Dai, Yutong Li, Yifang Zou, Lingzhi Wang, Shulan Han, Xuemei Zhang, Di Liang and Hao Yang and has published in prestigious journals such as Biomaterials, Science Advances and International Journal of Pharmaceutics.

In The Last Decade

Leilei Yang

12 papers receiving 409 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

2023 178 citations Shulan Han, Xueying Bao et al. Science Advances profile →

Peers

Countries citing papers authored by Leilei Yang

Since Specialization

Citations

This map shows the geographic impact of Leilei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilei Yang more than expected).

Fields of papers citing papers by Leilei Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leilei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilei Yang. The network helps show where Leilei Yang may publish in the future.

Co-authorship network of co-authors of Leilei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Leilei Yang. A scholar is included among the top collaborators of Leilei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilei Yang. Leilei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters 2025 ·Translational Oncology ·(unknown), Ruiqiang Li, Jiaolin Zhou, Peng Li, Gengchen Xie, Shenyi Yin, Leilei Yang, Guole Lin	0
2	Leveraging adenosine triphosphate for cancer theranostics 2025 ·Theranostics ·(unknown), Xinyu Zhang, Jianhua Wang, Kexin Wang, Xiaotian Li, Xianghe Qiao, Wei He, Jinghua Cai, Danfeng Liu, Leilei Yang	1
3	cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy 2024 ·European Polymer Journal ·(unknown), Junjun Chen, (unknown), Lingzhi Wang, Leilei Yang, Yutong Li, Yifang Zou, Jia Shi, (unknown), Zhuo Yu, Jianfeng Guo	5
4	Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy 2024 ·Biomaterials ·Lingzhi Wang, (unknown), Zhuo Li, (unknown), Yutong Li, Leilei Yang, (unknown), (unknown), (unknown), Yifang Zou, Xuemei Zhang, (unknown), (unknown), Zhuo Yu, Jianfeng Guo	19
5	Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma 2024 ·International Journal of Pharmaceutics ·Chenyu Cao, Yifei Li, (unknown), Shanshan Jiang, Yutong Li, Leilei Yang, (unknown), (unknown), (unknown), Huan Li, Shulan Han, Zhuo Yu, Yifang Zou, (unknown)	12
6	Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma 2023 ·International Journal of Pharmaceutics ·Yanan Li, Xiaoju Shi, Dandan Sun, Shulan Han, Yifang Zou, Lingzhi Wang, Leilei Yang, Yutong Li, Ying Shi, Jianfeng Guo, Caitríona M. O’Driscoll	14
7	d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma breakdown → 2023 ·Science Advances ·Shulan Han, Xueying Bao, Yifang Zou, Lingzhi Wang, Yutong Li, Leilei Yang, (unknown), Xuemei Zhang, Xin Jiang, Di Liang, Yun Dai, Qing‐Chuan Zheng, Zhuo Yu, Jianfeng Guo	178
8	Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity 2023 ·Fundamental Research ·Zhuo Yu, Yifang Zou, Shulan Han, Dandan Sun, Lingzhi Wang, Leilei Yang, Yutong Li, Xuemei Zhang, Jianfeng Guo	6
9	A tetramethylpyrazine-loaded hyaluronic acid-based hydrogel modulates macrophage polarization for promoting wound recovery in diabetic mice 2023 ·International Journal of Biological Macromolecules ·(unknown), Junjun Chen, Xingmei Liu, (unknown), (unknown), Yutong Li, Leilei Yang, Zheng Chen, Zhuo Yu, Jianfeng Guo	17
10	Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma 2023 ·International Journal of Pharmaceutics ·Linlin Li, Yifang Zou, Lingzhi Wang, Leilei Yang, Yutong Li, (unknown), Zheng Chen, Zhuo Yu, Jianfeng Guo, Shulan Han	18
11	PhcX Is a LqsR-family response regulator that contributes to Ralstonia solanacearum virulence and regulates multiple virulence factors 2023 ·mBio ·Qingmei Liu, Chuhao Li, Xiaohan Zhang, Mengfan Ding, (unknown), (unknown), Ming Hu, Leilei Yang, (unknown), Lisheng Liao, Peng Li, Xiaofan Zhou	2
12	A chlorogenic acid-loaded hyaluronic acid-based hydrogel facilitates anti-inflammatory and pro-healing effects for diabetic wounds 2022 ·Journal of Drug Delivery Science and Technology ·Song Liu, Hao Yang, Di Liang, (unknown), Leilei Yang, Meng Li, Bo Yang, Ying Shi, Zheng Chen, Zhuo Yu, Jianfeng Guo	26
13	Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing 2021 ·Materials Today Bio ·Hao Yang, Song Liu, (unknown), (unknown), Leilei Yang, Meng Li, Huan Li, Yun Dai, Zhuo Yu, Jianfeng Guo	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact